About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. (TMO) has been publicly traded since 1980, making it a 46-year-old public company. It operates in the Diagnostics & Research industry within the Healthcare sector. The company is headquartered in Waltham, United States and employs approximately 125,000 people. With a market capitalization of $173 billion, TMO is a large established company.
Key Statistics
- Current Price
- $466.56
- Market Cap
- $173.32B
- 52-Week High
- $643.99
- 52-Week Low
- $385.46
- Sector
- Healthcare
- Industry
- Diagnostics & Research
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | -19.48% | $579.45 | $466.55 |
| 2025 | +11.78% | $518.40 | $579.45 |
| 2024 | -1.72% | $527.48 | $518.40 |
| 2023 | -3.36% | $545.80 | $527.48 |
| 2022 | -17.29% | $659.86 | $545.80 |
| 2021 | +43.54% | $459.70 | $659.86 |
| 2020 | +43.72% | $319.86 | $459.70 |
| 2019 | +45.55% | $219.76 | $319.86 |
| 2018 | +18.21% | $185.91 | $219.76 |
| 2017 | +35.03% | $137.68 | $185.91 |
| 2016 | -0.12% | $137.84 | $137.68 |
| 2015 | +13.75% | $121.18 | $137.84 |
| 2014 | +13.06% | $107.18 | $121.18 |
| 2013 | +75.78% | $60.97 | $107.18 |
| 2012 | +43.17% | $42.59 | $60.97 |
| 2011 | -18.77% | $52.43 | $42.59 |
| 2010 | +16.08% | $45.16 | $52.43 |
| 2009 | +39.98% | $32.26 | $45.16 |
| 2008 | -40.93% | $54.62 | $32.26 |
| 2007 | +27.36% | $42.89 | $54.62 |
| 2006 | +50.32% | $28.53 | $42.89 |
| 2005 | -0.20% | $28.59 | $28.53 |
| 2004 | +19.80% | $23.86 | $28.59 |
| 2003 | +25.25% | $19.05 | $23.86 |
| 2002 | -15.67% | $22.60 | $19.05 |
| 2001 | -6.77% | $24.24 | $22.60 |
| 2000 | +98.33% | $12.22 | $24.24 |
| 1999 | -11.44% | $13.80 | $12.22 |
| 1998 | -61.51% | $35.85 | $13.80 |
| 1997 | +6.67% | $33.61 | $35.85 |
| 1996 | +19.00% | $28.24 | $33.61 |
| 1995 | +73.82% | $16.25 | $28.24 |
| 1994 | +6.85% | $15.21 | $16.25 |
| 1993 | +34.02% | $11.35 | $15.21 |
| 1992 | +1.07% | $11.23 | $11.35 |
| 1991 | +61.47% | $6.95 | $11.23 |
| 1990 | -5.71% | $7.37 | $6.95 |
| 1989 | +51.23% | $4.88 | $7.37 |
| 1988 | +48.62% | $3.28 | $4.88 |
| 1987 | -19.85% | $4.09 | $3.28 |
| 1986 | +26.71% | $3.23 | $4.09 |
| 1985 | +50.94% | $2.14 | $3.23 |
| 1984 | -9.09% | $2.35 | $2.14 |
| 1983 | +114.63% | $1.10 | $2.35 |
| 1982 | -27.65% | $1.52 | $1.10 |
| 1981 | -30.89% | $2.19 | $1.52 |
Valuation
TMO currently trades at a trailing P/E ratio of 26.2, which is considered high relative to the broader market. The forward P/E of 17.3 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 3.3. The price-to-sales ratio is 3.9.
Dividends
Thermo Fisher Scientific Inc. pays a dividend to shareholders with a current yield of 0.38%. This translates to $1.76 per share annually. The payout ratio of 10% indicates sustainable dividend coverage.
Risk & Volatility
TMO has a beta of 0.97, indicating it is similarly volatile to the overall market. The stock's 52-week range is $385.46 to $643.99, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 24 analyst opinions, TMO has a consensus "strong_buy" rating. The average price target of $663.96 suggests 43.0% upside from current levels.
Frequently Asked Questions
What does Thermo Fisher Scientific Inc. do? ▼
Thermo Fisher Scientific Inc. is a Diagnostics & Research company operating in the Healthcare sector. The company is headquartered in Waltham, United States.
What sector is TMO in? ▼
TMO operates in the Healthcare sector, specifically in the Diagnostics & Research industry.
When did TMO go public? ▼
Thermo Fisher Scientific Inc. went public in 1980, making it a 46-year-old public company as of 2026.
How much would $1,000 invested in TMO 5 years ago be worth today? ▼
A $1,000 investment in TMO five years ago would be worth approximately $1,055 today, representing a 5.5% return.
Does TMO pay dividends? ▼
Yes, Thermo Fisher Scientific Inc. pays a dividend with a current yield of 0.38%, which is $1.76 per share annually.
What is TMO's market cap? ▼
Thermo Fisher Scientific Inc. has a market capitalization of $173 billion, classifying it as a large-cap company.
What is TMO's P/E ratio? ▼
TMO has a trailing P/E ratio of 26.2 and a forward P/E of 17.3, which measures how much investors are paying per dollar of earnings.
Is TMO a buy, hold, or sell? ▼
Based on 24 opinions, TMO has a consensus "strong_buy" rating. The average price target is $663.96.
Last updated: 3/14/2026